Department of Cell Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Molecular and Translational Medicine, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing 100142, China.
Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
Nat Commun. 2015 Sep 30;6:8271. doi: 10.1038/ncomms9271.
Tumour-initiating cells (TICs) are advocated to constitute the sustaining force to maintain and renew fully established malignancy; however, the molecular mechanisms responsible for these properties are elusive. We previously demonstrated that voltage-gated calcium channel α2δ1 subunit marks hepatocellular carcinoma (HCC) TICs. Here we confirm directly that α2δ1 is a HCC TIC surface marker, and identify let-7c, miR-200b, miR-222 and miR-424 as suppressors of α2δ1(+) HCC TICs. Interestingly, all the four miRNAs synergistically target PBX3, which is sufficient and necessary for the acquisition and maintenance of TIC properties. Moreover, PBX3 drives an essential transcriptional programme, activating the expression of genes critical for HCC TIC stemness including CACNA2D1, EpCAM, SOX2 and NOTCH3. In addition, the expression of CACNA2D1 and PBX3 mRNA is predictive of poor prognosis for HCC patients. Collectively, our study identifies an essential signalling pathway that controls the switch of HCC TIC phenotypes.
肿瘤起始细胞 (TICs) 被认为构成了维持和更新完全建立的恶性肿瘤的维持力量; 然而,负责这些特性的分子机制尚不清楚。我们之前证明电压门控钙通道α2δ1 亚基标记肝癌 (HCC) TICs。在这里,我们直接证实 α2δ1 是 HCC TIC 的表面标志物,并确定 let-7c、miR-200b、miR-222 和 miR-424 是α2δ1(+) HCC TICs 的抑制物。有趣的是,所有这四种 miRNA 协同作用靶向 PBX3,这对于 TIC 特性的获得和维持是充分和必要的。此外,PBX3 驱动一个基本的转录程序,激活包括 CACNA2D1、EpCAM、SOX2 和 NOTCH3 在内的对 HCC TIC 干性至关重要的基因的表达。此外,CACNA2D1 和 PBX3 mRNA 的表达可预测 HCC 患者的预后不良。总之,我们的研究确定了一个控制 HCC TIC 表型转换的重要信号通路。